Skip to content

by transverse incision with longitudinal ligation

Clinical comparative study on the efficacy and safety of the treatment of circular hemorrhoids by transverse incision and longitudinal ligation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000407
Enrollment
Unknown
Registered
2024-09-08
Start date
2020-10-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mixed hemorrhoids

Interventions

Treatment group:Transverse incision and longitudinal ligation
Observation group:Milligan-Morgan

Sponsors

China-japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) According to the diagnostic criteria of annular mixed hemorrhoids in the Chinese Medicine Industry Standard of the People's Republic of China the diagnosis of mixed hemorrhoids can be diagnosed as annular hemorrhoids by combining any of the following items: a. The perianal hemorrhoids were distributed in 360° pananal canal. b. The anal canal is completely turned down with a toothed line moving down accordingly; c. The hemorrhoids show circular swelling or prolapse during stool. 2) Aged 18-60 years old first anal surgery. 3) It can tolerate surgical treatment without obvious contraindications. 4) Voluntarily undergo surgical treatment and sign informed consent.

Exclusion criteria

Exclusion criteria: 1) Younger than 18 years old or older than 61 years old 2) Patients with liver kidney cardiovascular and cerebrovascular diseases or tumors malnutrition endocrine and hematopoietic system and other serious primary diseases. 3) Patients with chronic diseases such as inflammatory bowel disease and tuberculosis. 4) Pregnant or lactating women and those who have mental disorders or other reasons can not cooperate with surgical treatment. 5) Allergic physique or allergic to related drugs.

Design outcomes

Primary

MeasureTime frame
Clinical efficacy evaluation;

Secondary

MeasureTime frame
Anal edema;Mean wound healing time;Anal stenosis;Anal function;Anal distention;Degree of wound pain;Urinary retention;

Countries

China

Contacts

Public ContactLixia Lai

China-japan Friendship Hospital

laixia86@163.com18710068600

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026